TipRanks
Celadon Group (CGIP)
OTHER OTC:CGIP
US Market

Celadon Group (CGIP) Stock Forecast & Price Target

58 Followers
See the Price Targets and Ratings of:

CGIP Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Celadon
Group
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

CGIP Stock 12 Month Forecast

There Are No Analyst Ratings for CGIP In The Last 3 Months.
Highest Price Target―Average Price Target―Lowest Price Target―
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

CGIP Financial Forecast

CGIP Earnings Forecast

The previous quarter’s earnings for CGIP were -$0.06.
The previous quarter’s earnings for CGIP were -$0.06.

CGIP Sales Forecast

The previous quarter’s earnings for CGIP were $265.73M.
The previous quarter’s earnings for CGIP were $265.73M.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
BMO Capital Analyst forecast on CGIP
Unknown Analyst
BMO Capital
Not Ranked
BMO Capital
$122
Buy
60999900.00%
Upside
Reiterated
04/27/26
BMO Capital Sticks to Its Buy Rating for Celadon Group (CGIP)
TD Cowen Analyst forecast on CGIP
Unknown Analyst
TD Cowen
Not Ranked
TD Cowen
$55
Buy
27499900.00%
Upside
Reiterated
04/09/26
H.C. Wainwright Analyst forecast on CGIP
Unknown Analyst
H.C. Wainwright
Not Ranked
H.C. Wainwright
―
Buy
―
Reiterated
02/12/26
Valuation and Risks. We value Alto Neuroscience using a sum-of-the-parts (SOTP) and risk-adjusted discounted cash flow (DCF) methodology. We assign probabilities of success of 30% to BPD, reflecting varying levels of clinical maturity and risk. We model annual equity raises of $100M-$200M from 2026E to 2029E, to fund clinical development and potential commercial launch expenses, which could dilute existing shareholders.
UBS Analyst forecast on CGIP
Unknown Analyst
UBS
Not Ranked
UBS
$95
Hold
47499900.00%
Upside
Reiterated
01/28/26
UBS Remains a Hold on Celadon Group (CGIP)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
BMO Capital Analyst forecast on CGIP
Unknown Analyst
BMO Capital
Not Ranked
BMO Capital
$122
Buy
60999900.00%
Upside
Reiterated
04/27/26
BMO Capital Sticks to Its Buy Rating for Celadon Group (CGIP)
TD Cowen Analyst forecast on CGIP
Unknown Analyst
TD Cowen
Not Ranked
TD Cowen
$55
Buy
27499900.00%
Upside
Reiterated
04/09/26
H.C. Wainwright Analyst forecast on CGIP
Unknown Analyst
H.C. Wainwright
Not Ranked
H.C. Wainwright
―
Buy
―
Reiterated
02/12/26
Valuation and Risks. We value Alto Neuroscience using a sum-of-the-parts (SOTP) and risk-adjusted discounted cash flow (DCF) methodology. We assign probabilities of success of 30% to BPD, reflecting varying levels of clinical maturity and risk. We model annual equity raises of $100M-$200M from 2026E to 2029E, to fund clinical development and potential commercial launch expenses, which could dilute existing shareholders.
UBS Analyst forecast on CGIP
Unknown Analyst
UBS
Not Ranked
UBS
$95
Hold
47499900.00%
Upside
Reiterated
01/28/26
UBS Remains a Hold on Celadon Group (CGIP)
Stocks with the Highest Top Analyst Consensus in the Industrials Sector
UALUnited Airlines Holdings
DYDycom
QXOQXO Inc
FTAIFTAI Aviation
MTZMasTec
Find stocks in the Industrials sector that are highly recommended by Top Performing Analysts.

CGIP Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
0
0
0
0
0
Buy
2
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
2
0
0
0
0
In the current month, CGIP has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. CGIP average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.

CGIP Stock Forecast FAQ

What is CGIP’s average 12-month price target, according to analysts?
Currently, no data Available
What is CGIP’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for CGIP, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is CGIP a Buy, Sell or Hold?
      Currently, no data Available
      What is Celadon Group’s price target?
      Currently, no data Available
      What do analysts say about Celadon Group?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of CGIP?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.